Back to News
Market Impact: 0.2
OAC Calls on Cigna to Listen to Employees and Restore GLP-1 Coverage
Source: PR Newswire
Healthcare & BiotechConsumer Demand & Retail
The Obesity Action Coalition is urging Cigna to reverse a decision to end health-plan coverage of GLP-1 weight-management medications for more than 50,000 U.S. employees. The policy change could restrict employee access to obesity treatments and underscores payer pressure to manage the high cost of GLP-1 drugs, though the announcement does not quantify Cigna's expected savings or financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
CI-0.58
More News
- Your health insurance premiums may take a big jump in 2027 — here's why
- Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
- Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
- Nike falls to 13-year low. Why analysts don't think the selling is over yet
- Nike’s Worsening Slump Forces CEO to Rethink Turnaround
- California leads lawsuit against Trump fuel efficiency standards rollback
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Adding Live MBO Level 3 Data - Liquidity Heatmap, OFI Charts, and More
- Alternative Data Due Diligence for Institutional Investors